In This Section      
 

Sherita Golden, MD, MHS

Ciccarone Center Research

Published By

Sherita Golden, MD, MHS

Sherita Golden, MD, MHS
Golden, Sherita, MD, MHS

Sherita Golden, MD, MHS, is the Director of Inpatient Diabetes Management Service and a Professor of Medicine.

View my Johns Hopkins Medicine profile for more information and to request an appointment.

 

Landmark Article

Mild cognitive dysfunction does not affect diabetes control in minority elders.

By: Palta P, Golden SH, Teresi JA, Palmas W, Trief P, Weinstock RS, Shea A, Manly JJ, Luchsinger JA.
Mild cognitive impairment was not associated with metabolic control of diabetes among minority elderly individuals.

Significant depressive symptoms are not associated with diabetes control in minority elderly.

By: Palta P, Golden SH, Teresi JA, Palmas W, Trief P, Weinstock RS, Shea A, Manly JJ, Luchsinger JA.
Elevated depressive symptoms were not associated with metabolic control of diabetes among minority elderly individuals.

Early readmission among patients with diabetes: A qualitative assessment of contributing factors.

By: Rubin DJ, Donnell-Jackson K, Jhingan R, Golden SH, Paranjape A.
Findings from this qualitative study suggest several interventions that may reduce the risk of early readmission for patients with diabetes, including inpatient diabetes education, improving communication of discharge instructions, and involving patients more in medication reconciliation and post-discharge planning.

Stability and predictors of change in salivary cortisol measures over six years: The Multi-Ethnic Study of Atherosclerosis.

By: Wang X, Sanchez BN, Golden SH, Shrager S, Kirschbaum C, Karlmangla AS, Seeman TE, Diez Roux AV.
All features of the daily cortisol curve changed significantly over the approximately six year follow-up period—the wakeup cortisol became higher; the cortisol awakening response became smaller; both the early and late decline became flatter and the area under the curve became larger.
Read on Pubmed

A community-engaged cardiovascular health disparities research training curriculum: Implementation and preliminary outcomes.

By: Golden SH, Purnell T, Halbert J, Matens R, Miller ER, Levine D, Nguyen TH, Gudzune KA, Crews DC, Mahlangu-Ngcobo M, Cooper LA.
This manuscript summarizes the key elements, implementation, and preliminary outcomes of the CVD Disparities Fellowship and Summer Internship Programs at the Johns Hopkins University Schools of Medicine, Nursing, and Bloomberg School of Public Health.

Difference by sex but not by race/ethnicity in the visceral adipose tissue-depressive symptoms association: The Multi-Ethnic Study of Atherosclerosis.

By: Remigio-Baker RA, Allison MA, Schreiner P, Szklo M, Crum RM, Leoutsakos J, Franco M, Carnethon MR, Nettleton J, Mujahid M, Diez Roux AV, Jensky N, Golden SH.
Sex, but not race/ethnicity, was found to modify the relationship between elevated depressive symptoms and visceral fat mass. Among men, a significant positive association was found between depressive symptoms and visceral adiposity, but no significant relationship was found among women.

NIDDK international conference report on diabetes and depression: Current understanding and future directions.

By: Holt RIG, deGroot M, Lucki I, Hunter CM, Sartorius N, Golden SH.
Comorbid diabetes and depression are a major clinical challenge as the outcomes of each condition are worsened by the other. This article summarizes the presentations and discussions during an international meeting on diabetes and depression convened by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in collaboration with the National Institute of Mental Health and the Dialogue on Diabetes and Depression.

Does hormone therapy affect blood pressure changes in the Diabetes Prevention Program?

By: Kim C, Golden SH, Kong S, Nan B, Mather KJ, Barrett-Connor, Diabetes Prevention Program Research Group.

Among overweight women with dysglycemia, the magnitude of blood pressure reductions after intensive lifestyle change is unrelated to postmenopausal estrogen use.

Diabetes and depression.

By: Holt RI, de Groot M, Golden SH.
Both psychological interventions and antidepressants are effective in treating depressive symptoms in people with diabetes but have mixed effects on glycemic control.

Does hormone therapy affect blood pressure in the Diabetes Prevention Program?

By: Kim C, Golden SH, Kong S, Nan B, Mather K, Barrett-Connor E; for the Diabetes Prevention Program Research Group.

This study aims to examine whether blood pressure reductions differ by estrogen use among overweight glucose-intolerant women. Among overweight women with dysglycemia, the magnitude of blood pressure reductions after ILS is unrelated to postmenopausal estrogen use.